These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12114495)

  • 41. High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil.
    Rocha JC; Silva RL; Mendonça BB; Marui S; Simpson AJ; Camargo AA
    J Med Genet; 2003 Mar; 40(3):e31. PubMed ID: 12624160
    [No Abstract]   [Full Text] [Related]  

  • 42. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. von Hippel-Lindau disease: a clinical and scientific review.
    Maher ER; Neumann HP; Richard S
    Eur J Hum Genet; 2011 Jun; 19(6):617-23. PubMed ID: 21386872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses).
    Hes FJ; Feldberg MA
    Eur Radiol; 1999; 9(4):598-610. PubMed ID: 10354869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
    Montera M; Bellone E; Ajmar F; Mandich P
    Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
    [No Abstract]   [Full Text] [Related]  

  • 46. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
    Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
    Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The von Hippel-Lindau tumor suppressor gene.
    Kondo K; Kaelin WG
    Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
    Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
    J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
    Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
    Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phaeochromocytoma associated with a de novo VHL mutation as form fruste of von Hippel-Lindau disease.
    Frenzel S; Apel TW; Heidemann PH; Zerres K; Neumann HP; Dörr HG
    Eur J Pediatr; 2001 Jul; 160(7):421-4. PubMed ID: 11475579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Von Hippel-Lindau disease.
    Maher ER
    Curr Mol Med; 2004 Dec; 4(8):833-42. PubMed ID: 15579030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.
    Martin R; Hockey A; Walpole I; Goldblatt J
    Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pediatric pheochromocytoma in association with Von Hippel-Lindau disease: Focus on screening strategies.
    Vérot PL; Rabattu PY; Chabre O; Gayot A; Sartelet H; Faguet R; Robert Y; Piolat C
    Arch Pediatr; 2020 Nov; 27(8):497-501. PubMed ID: 33067065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When Biochemical Phenotype Predicts Genotype: Pheochromocytoma and Paraganglioma.
    Yan Q; Bancos I; Gruber LM; Bancos C; McKenzie TJ; Babovic-Vuksanovic D; Young WF
    Am J Med; 2018 May; 131(5):506-509. PubMed ID: 29391129
    [No Abstract]   [Full Text] [Related]  

  • 56. Suprasellar hemangioblastoma in a patient with von Hippel-Lindau disease confirmed by germline mutation study: case report and review of the literature.
    Goto T; Nishi T; Kunitoku N; Yamamoto K; Kitamura I; Takeshima H; Kochi M; Nakazato Y; Kuratsu J; Ushio Y
    Surg Neurol; 2001 Jul; 56(1):22-6. PubMed ID: 11546565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinal angiomatosis and von Hippel-Lindau disease.
    Kreusel KM; Bechrakis NE; Heinichen T; Neumann L; Neumann HP; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):916-21. PubMed ID: 11148816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality.
    Bender BU; Eng C; Olschewski M; Berger DP; Laubenberger J; Altehöfer C; Kirste G; Orszagh M; van Velthoven V; Miosczka H; Schmidt D; Neumann HP
    J Med Genet; 2001 Aug; 38(8):508-14. PubMed ID: 11483638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovering a novel genetic variant in 11 family members who had isolated pheochromocytoma linked to von Hippel-Lindau (VHL) syndrome, aligning with the type 2c phenotype.
    Alhawari H; Obeidat Z; Wahbeh L; Mismar A; Younis N; Jafar H; Momani M; Alsabatin N; Awidi A; Alhawari H
    Blood Press; 2024 Dec; 33(1):2355268. PubMed ID: 38824681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent polytopic chromaffin paragangliomas in a 9-year-old boy resulting from a novel germline mutation in the von Hippel-Lindau gene.
    Reichardt P; Apel TW; Domula M; Tröbs RB; Krause I; Bierbach U; Neumann HP; Kiess W
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):145-8. PubMed ID: 11990703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.